Canadian General Medical Center Complex Company SJSC
Canadian General Medical Center Complex Company SJSC operates in the healthcare facilities and services industry, providing medical services and pharmaceuticals to its patients and clients.
Business. Canadian General Medical Center Complex Company SJSC (4021.SE) is a healthcare facilities and services provider engaged in pharmaceutical activities. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Canadian General Medical Center Complex Company SJSC (4021.SE) is a healthcare facilities and services provider engaged in pharmaceutical activities. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.
The company maintains a strong liquidity position, with a current ratio of 4.0, indicating that it has four times more current assets than current liabilities. However, its free cash flow is negative at -41,310, which may signal short-term cash flow constraints despite positive operating cash flow of 19,875,690. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.06, suggesting that it is not heavily leveraged.
Profitability metrics show a return on equity of 10.93% and a return on assets of 7.89%, both of which are strong indicators of efficient use of equity and assets. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and return generation. The company's operating income of 18,108,230 and net income of 10,496,890 reflect a healthy margin, although the gross profit of 43,492,360 suggests that cost management is a key area of focus.
Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data, but the absence of segment-specific revenue breakdowns implies that it may operate as a single business unit or that its segments are not publicly differentiated. This lack of segmentation could limit the ability to assess the performance of individual business lines or geographic regions.
The company's growth trajectory is not explicitly outlined in the available data, but the capital expenditure of -9,356,530 indicates a reduction in investment in long-term assets, which may suggest a focus on cost containment or a shift in strategic priorities. The absence of forward-looking guidance in the data makes it difficult to assess the company's future growth prospects.
Risk factors include a medium liquidity risk, as the company's free cash flow is negative and its net cash position is negative after subtracting total debt. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. The company's conservative capital structure and strong liquidity position mitigate some of these risks.
Recent events and filings are not detailed in the available data, but the company's financial performance and risk profile suggest that it is maintaining a stable position in the healthcare sector. The absence of recent significant events or disclosures does not necessarily indicate a lack of activity, but rather a lack of public information in the provided dataset.
- The company has a strong liquidity position with a current ratio of 4.0.
- It maintains a conservative capital structure with a low debt-to-equity ratio of 0.06.
- Profitability is robust, with a return on equity of 10.93% and a return on assets of 7.89%.
- Free cash flow is negative, indicating potential short-term cash flow constraints.
- The company's growth trajectory is unclear due to a lack of forward-looking guidance and reduced capital expenditures.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Canadian General Medical Center Complex Company SJSC Market data — financials · 2026-05-26